Clinical Trials Logo

Citation(s)

  •   Arch, J
    J., & Abramowitz, J. S. (2015). Exposure therapy for obsessive-compulsive disorder: An optimizing inhibitory learning approach. Journal of Obsessive-Compulsive and Related Disorders, 6, 174-182.
  •   Birmaher B, Khetarpal S, Brent D, Cully M, Balach L, Kaufman J, Neer SM
    The Screen for Child Anxiety Related Emotional Disorders (SCARED): scale construction and psychometric characteristics. J Am Acad Child Adolesc Psychiatry. 1997 Apr;36(4):545-53.
  •   Cheron DM, Ehrenreich JT, Pincus DB
    Assessment of parental experiential avoidance in a clinical sample of children with anxiety disorders. Child Psychiatry Hum Dev. 2009 Sep;40(3):383-403. doi: 10.1007/s10578-009-0135-z. Epub 2009 Mar 12.
  •   Craske MG, Kircanski K, Zelikowsky M, Mystkowski J, Chowdhury N, Baker A
    Optimizing inhibitory learning during exposure therapy. Behav Res Ther. 2008 Jan;46(1):5-27. Epub 2007 Oct 7. Review.
  •   Craske MG, Treanor M, Conway CC, Zbozinek T, Vervliet B
    Maximizing exposure therapy: an inhibitory learning approach. Behav Res Ther. 2014 Jul;58:10-23. doi: 10.1016/j.brat.2014.04.006. Epub 2014 May 9.
  •   Deacon B, Kemp JJ, Dixon LJ, Sy JT, Farrell NR, Zhang AR
    Maximizing the efficacy of interoceptive exposure by optimizing inhibitory learning: a randomized controlled trial. Behav Res Ther. 2013 Sep;51(9):588-96. doi: 10.1016/j.brat.2013.06.006. Epub 2013 Jul 6.
  •   Ehrenreich-May, J
    , Kennedy, S. M., Sherman, J., Bilek, E. L., Buzzella, B., Bennett, S., & Barlow, D. H. (In press). Unified protocols for transdiagnostic treatment of emotional disorders in children and adolescents. New York: Oxford University Press.
  •   Foa EB, Kozak MJ
    Emotional processing of fear: exposure to corrective information. Psychol Bull. 1986 Jan;99(1):20-35.
  •   Greco LA, Lambert W, Baer RA
    Psychological inflexibility in childhood and adolescence: development and evaluation of the Avoidance and Fusion Questionnaire for Youth. Psychol Assess. 2008 Jun;20(2):93-102. doi: 10.1037/1040-3590.20.2.93.
  •   Higa-McMillan CK, Francis SE, Rith-Najarian L, Chorpita BF
    Evidence Base Update: 50 Years of Research on Treatment for Child and Adolescent Anxiety. J Clin Child Adolesc Psychol. 2016;45(2):91-113. doi: 10.1080/15374416.2015.1046177. Epub 2015 Jun 18. Review.
  •   Larsen DL, Attkisson CC, Hargreaves WA, Nguyen TD
    Assessment of client/patient satisfaction: development of a general scale. Eval Program Plann. 1979;2(3):197-207.
  •   Milad MR, Pitman RK, Ellis CB, Gold AL, Shin LM, Lasko NB, Zeidan MA, Handwerger K, Orr SP, Rauch SL
    Neurobiological basis of failure to recall extinction memory in posttraumatic stress disorder. Biol Psychiatry. 2009 Dec 15;66(12):1075-82. doi: 10.1016/j.biopsych.2009.06.026. Epub 2009 Sep 12.
  •   Muris, P
    , Merckelbach, H., van Brakel, A., Mayer, B., & van Dongen, L. (1998). The Screen for Child Anxiety Related Emotional Disorders (SCARED): Relationship with anxiety and depression in normal children. Personality and Individual Differences, 24(4), 451-456.
  •   Shin LM, Liberzon I
    The neurocircuitry of fear, stress, and anxiety disorders. Neuropsychopharmacology. 2010 Jan;35(1):169-91. doi: 10.1038/npp.2009.83. Review.
  •   Simons, J
    S., & Gaher, R. M. (2005). The Distress Tolerance Scale: Development and validation of a self-report measure. Motivation and Emotion, 29(2), 83-102.
  •   Whiteside SP, Ale CM, Young B, Dammann JE, Tiede MS, Biggs BK
    The feasibility of improving CBT for childhood anxiety disorders through a dismantling study. Behav Res Ther. 2015 Oct;73:83-9. doi: 10.1016/j.brat.2015.07.011. Epub 2015 Jul 29.
  •   Whiteside SP, Gryczkowski M, Ale CM, Brown-Jacobsen AM, McCarthy DM
    Development of child- and parent-report measures of behavioral avoidance related to childhood anxiety disorders. Behav Ther. 2013 Jun;44(2):325-37. doi: 10.1016/j.beth.2013.02.006. Epub 2013 Mar 4.

Testing an Inhibitory Learning Model of Extinction in Exposure-Based Anxiety Treatment for Youth: Feasibility, Acceptability, and Efficacy

Details for clinical trial NCT03372915